Mayor F - Search Results

1

The Role of ACKR3 in Breast, Lung, and Brain Cancer.

Neves M, Fumagalli A, van den Bor J, Marin P, Smit MJ, Mayor F. Neves M, et al. Among authors: mayor f. Mol Pharmacol. 2019 Dec;96(6):819-825. doi: 10.1124/mol.118.115279. Epub 2019 Feb 11. Mol Pharmacol. 2019. PMID: 30745320 Free article. Review.

2

The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets.

Penela P, Murga C, Ribas C, Lafarga V, Mayor F Jr. Penela P, et al. Among authors: mayor f jr. Br J Pharmacol. 2010 Jun;160(4):821-32. doi: 10.1111/j.1476-5381.2010.00727.x. Br J Pharmacol. 2010. PMID: 20590581 Free PMC article. Review.

3

G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis.

Nogués L, Reglero C, Rivas V, Salcedo A, Lafarga V, Neves M, Ramos P, Mendiola M, Berjón A, Stamatakis K, Zhou XZ, Lu KP, Hardisson D, Mayor F Jr, Penela P. Nogués L, et al. Among authors: mayor f jr. EBioMedicine. 2016 Nov;13:132-145. doi: 10.1016/j.ebiom.2016.09.030. Epub 2016 Oct 1. EBioMedicine. 2016. PMID: 27720394 Free PMC article.

4

G-Protein-Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer.

Nogués L, Reglero C, Rivas V, Neves M, Penela P, Mayor F Jr. Nogués L, et al. Among authors: mayor f jr. Mol Pharmacol. 2017 Mar;91(3):220-228. doi: 10.1124/mol.116.107185. Epub 2016 Nov 28. Mol Pharmacol. 2017. PMID: 27895163 Review.

5

G protein-coupled receptor kinases (GRKs) in tumorigenesis and cancer progression: GPCR regulators and signaling hubs.

Nogués L, Palacios-García J, Reglero C, Rivas V, Neves M, Ribas C, Penela P, Mayor F Jr. Nogués L, et al. Among authors: mayor f jr. Semin Cancer Biol. 2018 Feb;48:78-90. doi: 10.1016/j.semcancer.2017.04.013. Epub 2017 May 1. Semin Cancer Biol. 2018. PMID: 28473253 Review.

6

CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status.

Fumagalli A, Zarca A, Neves M, Caspar B, Hill SJ, Mayor F Jr, Smit MJ, Marin P. Fumagalli A, et al. Among authors: mayor f jr. Mol Pharmacol. 2019 Dec;96(6):794-808. doi: 10.1124/mol.118.115360. Epub 2019 Mar 5. Mol Pharmacol. 2019. PMID: 30837297 Free article. Review.

7

The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting.

Smit MJ, Schlecht-Louf G, Neves M, van den Bor J, Penela P, Siderius M, Bachelerie F, Mayor F Jr. Smit MJ, et al. Among authors: mayor f jr. Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:541-563. doi: 10.1146/annurev-pharmtox-010919-023340. Epub 2020 Sep 21. Annu Rev Pharmacol Toxicol. 2021. PMID: 32956018

8

Modulation of CXCR4-Mediated Gi1 Activation by EGF Receptor and GRK2.

Neves M, Perpiñá-Viciano C, Penela P, Hoffmann C, Mayor F Jr. Neves M, et al. Among authors: mayor f jr. ACS Pharmacol Transl Sci. 2020 Apr 27;3(4):627-634. doi: 10.1021/acsptsci.0c00021. eCollection 2020 Aug 14. ACS Pharmacol Transl Sci. 2020. PMID: 33073183 Free PMC article.

9

Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells.

Neves M, Marolda V, Mayor F Jr, Penela P. Neves M, et al. Among authors: mayor f jr. Int J Mol Sci. 2022 Oct 6;23(19):11887. doi: 10.3390/ijms231911887. Int J Mol Sci. 2022. PMID: 36233192 Free PMC article.

10

Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases.

Elorza A, Sarnago S, Mayor F Jr. Elorza A, et al. Among authors: mayor f jr. Mol Pharmacol. 2000 Apr;57(4):778-83. doi: 10.1124/mol.57.4.778. Mol Pharmacol. 2000. PMID: 10727525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters